相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma-based microRNA signatures in early diagnosis of breast cancer
Xu Li et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
The relationship of human tissue microRNAs with those from body fluids
Chunmei Cui et al.
SCIENTIFIC REPORTS (2020)
Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
Peter McAnena et al.
BMC CANCER (2019)
miR-425-5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN
Sheng Xiao et al.
ONCOLOGY REPORTS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Circulating miR-21 and miR-155 as potential noninvasive biomarkers in Iranian Azeri patients with breast carcinoma
Elaheh Soleimanpour et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Expression analysis of miR-100 and selected genes from mTOR pathway in breast cancer patients
Roshanak Shams et al.
META GENE (2019)
microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1
Xiaowei Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients
Solmaz Khalighfard et al.
SCIENTIFIC REPORTS (2018)
miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression
Yanling Ding et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
Farah J. Nassar et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
Wenrui Wang et al.
CELL DEATH & DISEASE (2017)
miR-21 is involved in transforming growth factor β1-induced chemoresistance and invasion by targeting PTEN in breast cancer
Xiaomeng Dai et al.
ONCOLOGY LETTERS (2017)
microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis
Farah J. Nassar et al.
SCIENTIFIC REPORTS (2017)
Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients
Amal Qattan et al.
BMC CANCER (2017)
miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development
Nina Petrovic
MOLECULAR DIAGNOSIS & THERAPY (2016)
Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers
Hankui Chen et al.
JOURNAL OF CANCER (2016)
Missed Breast Cancer: What Can We Learn?
Anubha Wadhwa et al.
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY (2016)
Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection
Nerea Matamala et al.
CLINICAL CHEMISTRY (2015)
A historic and scientific review of breast cancer: The next global healthcare challenge
Sven Becker
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)
Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer
Sanaa Eissa et al.
TRANSLATIONAL RESEARCH (2015)
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
Isabel Stückrath et al.
Oncotarget (2015)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line
Xi Gu et al.
MEDICAL SCIENCE MONITOR (2015)
A novel panel of microRNAs provides a sensitive and specific tool for the diagnosis of breast cancer
Jinhua Luo et al.
MOLECULAR MEDICINE REPORTS (2014)
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2014)
miRNA as Potential Biomarkers of Breast Cancer in the Lebanese Population and in Young Women: A Pilot Study
Farah J. Nassar et al.
PLOS ONE (2014)
Serum circulating microRNA profiling for identification of potential breast cancer biomarkers
Fermin Mar-Aguilar et al.
DISEASE MARKERS (2013)
The Potential Role of miR-451 in Cancer Diagnosis, Prognosis, and Therapy
Xuan Pan et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
miR-139-5p is a regulator of metastatic pathways in breast cancer
Keerthana Krishnan et al.
RNA (2013)
MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems
Hector Herranz et al.
GENES & DEVELOPMENT (2010)
Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
Fengjun Wang et al.
GYNECOLOGIC ONCOLOGY (2010)
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Hua Zhao et al.
PLOS ONE (2010)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
分享论文
